Sun, Y., Yin, Z., Li, S., Wu, L., Zhang, Y., Zhao, Y., . . . Xu, L. (2024). Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer. British Journal of Cancer, 131(10), 1683. https://doi.org/10.1038/s41416-024-02863-9
Chicago Style (17th ed.) CitationSun, Yao, et al. "Losartan Rewires the Tumor-immune Microenvironment and Suppresses IGF-1 to Overcome Resistance to Chemo-immunotherapy in Ovarian Cancer." British Journal of Cancer 131, no. 10 (2024): 1683. https://doi.org/10.1038/s41416-024-02863-9.
MLA (9th ed.) CitationSun, Yao, et al. "Losartan Rewires the Tumor-immune Microenvironment and Suppresses IGF-1 to Overcome Resistance to Chemo-immunotherapy in Ovarian Cancer." British Journal of Cancer, vol. 131, no. 10, 2024, p. 1683, https://doi.org/10.1038/s41416-024-02863-9.